Kapitalo Investimentos Ltda Halozyme Therapeutics, Inc. Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$33.32 - $42.1 $187,291 - $236,644	-5,621 Reduced 61.0%	3,593 $133 Million
Q3 2023 Mar 29, 2024	BUY	$36.46 - $44.03 $335,942 - $405,692	9,214 New	9,214 $352 Million
Q2 2023 Mar 29, 2024	SELL	$30.28 - $38.74 $108,251 - $138,495	-3,575 Closed	0 $0
Q1 2023 Mar 29, 2024	BUY	$32.86 - $55.7 $117,474 - $199,127	3,575 New	3,575 $137 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.